The federal government is shifting its stance towards state-licensed medical marijuana, no longer grouping it with heroin. This shift could be a significant step forward for both businesses and patients. The change could result in significant tax relief for businesses like Swade, allowing them to deduct expenses for the first time. The shift also removes barriers to research on cannabis safety and effectiveness.